Audience
Those who want to understand what is done to bring new treatments to patients, and/or better operate with the language of internal customers. Typically people in non life-science technical roles in our sector – IT, Finance, HR and Admin staff. Also helpful for early research professionals who wish to broaden their knowledge of later stage development.
Objectives
This course generates understanding of the range of activities that take a new candidate drug molecule through Development, Manufacturing and Commercialization to routine patient use.
It is ideally designed to take up from the end point of the ‘Introduction to Drug Discovery’ course.
The general industry structure (pharmaceutical, biotechnology and vaccines) background is also explored; who are the players, how big/small, how do they interact with each other and with various service organisations.
It is a highly interactive, clearly explained journey through:
- Technical development – making the molecule and the medicine
- Preclinical safety – ensuring drugs are safe enough for patient use
- Early clinical trials – evaluating viability of new drugs
- Integrating healthcare with digital support and advanced diagnostics
- Major trials and Regulatory – proving value and seeking license to market
- Branding and commercialization for launch
- Manufacturing and supply chain set up
- Getting new treatments to patients worldwide
Costs
One Nucleus Gold: £392 + VAT
One Nucleus Silver: £476 + VAT
Non-members: £560 + VAT
For more details and registration: https://onenucleus.com/civicrm/event/info%3Fid%3D1659%26reset%3D1
